Sector News

Nestlé unveils platform providing diet-related health data for 190 countries

November 28, 2021
Life sciences

Nestlé and the Friedman School of Nutrition Science and Policy at US-based Tufts University have launched the Global Nutrition and Health Atlas (GNHA), a new online platform that provides free access to global nutrition and health data for over 190 countries.

The GNHA supports groups that need easily accessible nutrition and health information, such as stakeholders, researchers, health practitioners, policymakers and advocates for healthy nutrition.

“The platform is a place to drive innovation and for people to collaborate. Many data platforms are restrictive, isolated or stagnant,” says Elena Naumova, chair of the division of nutrition data science at Friedman School.

“However, with the Atlas, one can merge information from multiple sources to pull data from different locations and years. Also, one can get tips on how to use it, and this usability supports the wide array of health and nutrition needs around the world.”

Collecting and visualizing data
The GNHA includes data from established sources, including international agencies, NGOs, academic institutes and peer-reviewed studies.

“At Nestlé, in addition to our research partnerships, we draw on public health data to develop science-based nutritional concepts for people across life stages around the world,” says Eline Van Der Beek, head of Nestlé Institute of Health Sciences.

“This platform makes it easy for Nestlé scientists, as well as academic researchers and other external stakeholders, to access reliable data in a quick, interactive and user-friendly way.”

The platform collects and visualizes data on six nutrition and health dashboards, including demographics, dietary intake, nutritional status, health status, health economics and food sustainability.

Each dashboard features data shown in maps and charts to reflect characteristics in geography, frequency and time trends. All dashboards can be downloaded in various formats for further circulation.

Accurate labeling and nutrition profiling
Key industry players have made efforts to ensure accurate F&B labeling and consumer understanding of nutrient profiles.

Last month, the Friedman School of Nutrition Science and Policy at Tufts University developed the Food Compass. A new nutrition profiling system aims to encourage consumers and food companies to choose and produce healthier foods.

In the same month, Action on Salt and Sugar called for the UK government to make front-of-pack nutrition labels mandatory without delay following a systematic review and meta-analysis.

Meanwhile, the European Consumer Organization recently raised the need for accurate food labeling for the children’s food sector as it found that children’s packaging praised unhealthy food consumption.

By Nicole Kerr


comments closed

Related News

June 24, 2022

Echosens and Novo Nordisk announce partnership to increase awareness and advance early diagnosis of NASH

Life sciences

Echosens, a high-technology company offering liver diagnostic solutions, and Novo Nordisk A/S, a leading global healthcare company, announced a partnership to advance early diagnosis of non-alcoholic steatohepatitis (NASH) and increase awareness of the disease among patients, healthcare providers and other stakeholders.

June 24, 2022

argenx receives positive CHMP opinion for Efgartigimod for the treatment of adult patients with Generalized Myasthenia Gravis in Europe

Life sciences

Positive opinion based on Phase 3 ADAPT trial showing efgartigimod provided clinically meaningful improvements in strength and quality of life measures. If approved, efgartigimod will be the first neonatal Fc receptor (FcRn) blocker for the treatment of adults in Europe living with rare neuromuscular disease generalized myasthenia gravis (gMG).

June 24, 2022

Galapagos finally takes M&A plunge, spending $251M for 2 biotechs in CAR-T push

Life sciences

Galapagos CEO Paul Stoffels, M.D., has finally taken the plunge on M&A. The newly minted chief executive has signed not one but two deals in an attempt to right the ship, bringing two small biotechs aboard for a combined 239 million euros ($251.4 million).